EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Omega-3 polyunsaturated fatty acids and the psychiatric post-acute sequelae of COVID-19: A one-year retrospective cohort analysis of 33,908 patients

Ting-Hui Liu, Chung-Han Ho, Daniel Tzu-Li Chen, Jheng-Yan Wu, Po-Yu Huang, Chih-Cheng Lai, Kuang-Yang Hsieh, Kuan-Pin Su

Brain, Behavior, and Immunity · 2023

DOI: 10.1016/j.bbi.2023.09.008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, Behavior, and Immunity, 2023. Verfasst von Ting-Hui Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry, Chi Mei Medical Center, Tainan, Taiwan. Hauptthemen laut MEDLINE: Fatty Acids, Omega-3, COVID-19, Mental Disorders. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Education, Tainan Municipal An-Nan Hospital-China Medical University, Ministry of Science and Technology, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Early prevention and management of psychiatric symptoms in long COVID (or post-COVID-19 conditions) are crucial for reducing long-term disability. Existing clinical guidelines recommend the use of omega-3 polyunsaturated fatty acids (PUFAs) as a promising therapeutic approach for various common psychiatric disorders due to their anti-inflammatory and neuroprotective characteristics. This study aims to investigate the potential efficacy of omega-3 PUFAs in alleviating the psychiatric sequelae following COVID-19. METHODS: This 1-year retrospective cohort study used the TriNetX electronic health records network to examine the effects of omega-3 PUFAs supplements on psychiatric sequelae in adults diagnosed with COVID-19. Using propensity-score matching, the study compared those who used omega-3 PUFAs supplements with those who did not, assessing outcomes including depression, anxiety disorders, insomnia, and other somatic conditions up to a year after COVID-19 diagnosis. RESULTS: In 16,962 patients who received omega-3 PUFAs supplements and 2,248,803 who did not, omega-3 supplementation significantly reduced the risk of developing psychiatric sequelae post-COVID-19 diagnosis (HR, 0.804; 95% CI, 0.729 to 0.888). Specifically, the risks for depression (HR, 0.828; 95% CI, 0.714 to 0.960), anxiety disorders (HR, 0.833; 95% CI, 0.743 to 0.933), and insomnia (HR, 0.679; 95% CI, 0.531 to 0.869) were reduced in the omega-3 group. This effect was consistent across sex, race, 18-59 age group, and patients with less than two doses of the COVID-19 vaccine. The omega-3 group also had a lower risk of cough and myalgia, but no significant difference was noted for other symptoms like chest pain, abnormal breathing, abdominal issues, fatigue, headache, and cognitive symptoms. CONCLUSION: Omega-3 PUFAs may require re-evaluation as a preventive strategy against adverse mental health outcomes post-COVID-19 in placebo-controlled clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty Acids, Omega-3COVID-19Mental DisordersHumansFemaleMaleRetrospective StudiesMiddle AgedAdultDietary SupplementsSleep Initiation and Maintenance DisordersSARS-CoV-2AgedAnxiety DisordersDepressionPandemics

Stichwörter der Autor:innen

Long-COVIDOmega-3 PUFAsPost-COVID-19 conditionPsychiatricSARS-CoV-2

Substanzen

Fatty Acids, Omega-3

Autor:innen und Institutionen

  • Department of Psychiatry, Chi Mei Medical Center, Tainan, Taiwan.
  • Department of Medical Research, Chi Mei Medical Center, Tainan, Taiwan.
  • School of Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung, Taiwan; Mind-Body Interface Research Center (MBI-Lab), China Medical University Hospital, Taichung, Taiwan; Graduate Institute…
  • Department of Nutrition, Chi Mei Medical Center, Tainan City, Taiwan.
  • Department of Internal Medicine, Chi Mei Medical Center, Tainan City, Taiwan.
  • Division of Hospital Medicine, Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan; School of Medicine, College of Medicine, National Sun Yat-sen University, Kaohsiung, Taiwan.

Förderung

  • Ministry of Education
  • Tainan Municipal An-Nan Hospital-China Medical University
  • Ministry of Science and Technology, Taiwan
  • China Medical University Hospital
  • China Medical University, Taiwan
  • National Science and Technology Council

Zitieren

APA

Liu, T. H., Ho, C. H., Chen, D. T., Wu, J. Y., Huang, P. Y., Lai, C. C., Hsieh, K. Y., & Su, K. P. (2023). Omega-3 polyunsaturated fatty acids and the psychiatric post-acute sequelae of COVID-19: A one-year retrospective cohort analysis of 33,908 patients. Brain, Behavior, and Immunity. https://doi.org/10.1016/j.bbi.2023.09.008

Vancouver

Liu TH, Ho CH, Chen DT, Wu JY, Huang PY, Lai CC, et al. Omega-3 polyunsaturated fatty acids and the psychiatric post-acute sequelae of COVID-19: A one-year retrospective cohort analysis of 33,908 patients. Brain, Behavior, and Immunity. 2023. doi:10.1016/j.bbi.2023.09.008

BibTeX
@article{Liu2023,
  author = {Liu, Ting-Hui and Ho, Chung-Han and Chen, Daniel Tzu-Li and Wu, Jheng-Yan and Huang, Po-Yu and Lai, Chih-Cheng and Hsieh, Kuang-Yang and Su, Kuan-Pin},
  title = {Omega-3 polyunsaturated fatty acids and the psychiatric post-acute sequelae of COVID-19: A one-year retrospective cohort analysis of 33,908 patients},
  journal = {Brain, Behavior, and Immunity},
  year = {2023},
  doi = {10.1016/j.bbi.2023.09.008}
}
Kostenlos starten →